Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUTERA INCCUTR · Entity 82936 | Director | October 24, 2024 | November 05, 2024 |
| Sientra, Inc.SIEN · Entity 108294 | Director | June 09, 2022 | June 14, 2022 |
| Venus Concept Inc.VERO · Entity 55304 | Director | March 24, 2023 | March 28, 2023 |
| Zeltiq Aesthetics IncZLTQ · Entity 176636 | CCO, President, North America | January 04, 2017 | January 06, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUTERA INC
Report date October 24, 2024 · Filed November 05, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.65 · Expires 2031-10-23 | Direct | 20,000 |
Reported balance
After 2024-10-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-10-24 · Grant · Acquired 20,000 · Balance 20,000 F1: All shares vest on the earlier of 12 months from grant date, or on the day of the 2025 annual stockholder meeting, subject to the Reporting Person continuing to be a service provider of the Company. F2: The expiration date is subject to earlier expiration upon the termination of the Reporting Person's service with the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: All shares vest on the earlier of 12 months from grant date, or on the day of the 2025 annual stockholder meeting, subject to the Reporting Person continuing to be a service provider of the Company.
F2: The expiration date is subject to earlier expiration upon the termination of the Reporting Person's service with the Company.
Sientra, Inc.
Report date June 09, 2022 · Filed June 14, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 370,354 |
Reported balance
After 2022-06-09 transaction · row 1
1 source rowRow 1 · 2022-06-09 · Grant · Acquired 103,306 · Balance 370,354 F1: The Restricted Stock Units shall vest on the earlier to occur of: (i) the day prior to the 2023 Annual Shareholders Meeting or (ii) on the one (1) year anniversary of the Annual Shareholders Meeting on which the Restricted Stock Award was granted, subject to continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units shall vest on the earlier to occur of: (i) the day prior to the 2023 Annual Shareholders Meeting or (ii) on the one (1) year anniversary of the Annual Shareholders Meeting on which the Restricted Stock Award was granted, subject to continued service.
Venus Concept Inc.
Report date March 24, 2023 · Filed March 28, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.19 · Expires 2033-03-24 | Direct | 75,000 |
Reported balance
After 2023-03-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-03-24 · Purchase · Acquired 75,000 · Balance 75,000 F1: The options vest with respect to 1/16th of the underlying Common Stock on each quarterly anniversary of the date of grant, subject to continued service through each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest with respect to 1/16th of the underlying Common Stock on each quarterly anniversary of the date of grant, subject to continued service through each applicable vesting date.
Zeltiq Aesthetics Inc
Report date January 04, 2017 · Filed January 06, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 79,198 |
Ending reported balance
After 2017-01-04 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2017-01-04 · Exercise / conversion · Acquired 8,000 · Balance 87,198 Row 2 · 2017-01-04 · Sale · Disposed 7,700 · Balance 79,498 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.86 to $44.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Row 3 · 2017-01-04 · Sale · Disposed 100 · Balance 79,398 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Row 4 · 2017-01-04 · Sale · Disposed 100 · Balance 79,298 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Row 5 · 2017-01-04 · Sale · Disposed 100 · Balance 79,198 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.21 · Expires 2022-10-04 | Direct | 74,000 |
Reported balance
After 2017-01-04 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-01-04 · Exercise / conversion · Disposed 8,000 · Balance 74,000 F3: 25% of the total number of shares subject to the option vested on October 4, 2013, and the remainder vest in equal monthly installments over a 36-month period thereafter, subject to the Reporting Person's continued service to the Issuer. |
| Common StockSEC Table I · non-derivative | IndirectBy Keith J Sullivan (IRA) FCC as custodian | 5,000 |
Reported balance
Holding disclosure · report date 2017-01-04 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 5,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.86 to $44.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3: 25% of the total number of shares subject to the option vested on October 4, 2013, and the remainder vest in equal monthly installments over a 36-month period thereafter, subject to the Reporting Person's continued service to the Issuer.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Neuronetics, Inc.
Report date March 19, 2026 · Filed March 24, 2026
Section 16 reporting ended · disclosed 2026-03-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,590,924 |
Reported balance
After 2026-03-19 transaction · row 1
1 source rowRow 1 · 2026-03-19 · Sale · Disposed 46,289 · Balance 1,590,924 F1: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a performance restricted stock unit award. F2: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.48 to $1.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a performance restricted stock unit award.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.48 to $1.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 19, 2026 Filed Mar 24, 2026 21:50 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 46,289 | $1.34 | $62,027.26 |
DisclosureSEC source: 0001193125-26-122295 · ownership.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Former Officer & Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,590,924 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a performance restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.48 to $1.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 17, 2026 Filed Mar 18, 2026 20:34 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 112,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-114117 · ownership.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,637,213 F1 · price: Common stock received for no consideration upon the satisfaction of performance criteria underlying an award of performance based restricted stock units. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:33 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 8,452 | $1.35 | $11,410.20 |
DisclosureSEC source: 0001193125-26-082872 · ownership.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,524,713 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.38 to $1.31. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 22:44 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 33,847 | $1.65 | $55,847.55 |
DisclosureSEC source: 0001193125-26-057541 · ownership.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,533,165 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.56 to $1.72. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:31 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 40,976 | $1.55 | $63,512.80 |
DisclosureSEC source: 0001193125-26-048847 · ownership.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,567,012 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.45 to $1.60. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 22:49 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantPerformance Restricted Stock Unit · Derivative | 187,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028008 · ownership.xml · derivative · entry 2 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,500 Underlying: Common Stock · 187,500 shares Expires 2028-07-01 F3 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") represents a contingent right to recieve one share of the Issuer's common stock. F4 · shares: Represents a PRSU award granted on February 24, 2025 and vesting in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% and 110% of the target for each fiscal year ending December 31, 2025, 2026 and 2027. F3 · price: Each performance restricted stock unit ("PRSU") represents a contingent right to recieve one share of the Issuer's common stock. F4 · derivative.exercise_date: Represents a PRSU award granted on February 24, 2025 and vesting in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% and 110% of the target for each fiscal year ending December 31, 2025, 2026 and 2027. F4 · derivative.expiration_date: Represents a PRSU award granted on February 24, 2025 and vesting in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% and 110% of the target for each fiscal year ending December 31, 2025, 2026 and 2027. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 22:49 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 375,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028008 · ownership.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,607,988 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 24, 2026, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 24, 2025 Filed Mar 13, 2025 21:30 UTC Amendment | Neuronetics, Inc. STIM · Entity 6248 | GrantPerformance Restricted Stock Unit · Derivative | 187,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-038913 · ownership.xml · derivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,500 Underlying: Common Stock · 187,500 shares Expires 2028-07-01 F1 · shares: The Form 4 filed on February 26, 2025 inadvertently reported that the performance restricted stock unit ("PRSU") award granted on February 24, 2025 vests in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The correct vesting dates are December 31, 2025, 2026 and 2027. The Form 4 also reported that the Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% (the "Threshold Achievement") and 110% of the target for each vesting year. However, the correct Threshold Achievement is 90%. The number of shares reflected in column 7 assumes the maximum potential vest in each vesting year. F1 · derivative.exercise_date: The Form 4 filed on February 26, 2025 inadvertently reported that the performance restricted stock unit ("PRSU") award granted on February 24, 2025 vests in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The correct vesting dates are December 31, 2025, 2026 and 2027. The Form 4 also reported that the Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% (the "Threshold Achievement") and 110% of the target for each vesting year. However, the correct Threshold Achievement is 90%. The number of shares reflected in column 7 assumes the maximum potential vest in each vesting year. F1 · derivative.expiration_date: The Form 4 filed on February 26, 2025 inadvertently reported that the performance restricted stock unit ("PRSU") award granted on February 24, 2025 vests in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The correct vesting dates are December 31, 2025, 2026 and 2027. The Form 4 also reported that the Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% (the "Threshold Achievement") and 110% of the target for each vesting year. However, the correct Threshold Achievement is 90%. The number of shares reflected in column 7 assumes the maximum potential vest in each vesting year. Read SEC document |
| February 19, 2025 Filed Feb 20, 2025 22:21 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 24,440 | $4.70 | $114,868.00 |
DisclosureSEC source: 0000950170-25-024308 · ownership.xml · nonDerivative · entry 2 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,232,988 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $4.60 to $4.77. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:21 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 25,934 | $4.41 | $114,368.94 |
DisclosureSEC source: 0000950170-25-024308 · ownership.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,257,428 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $4.29 to $4.55. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 22:05 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 40,992 | $3.28 | $134,453.76 |
DisclosureSEC source: 0000950170-25-018968 · ownership.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,283,362 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.51 to $3.95. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 22:00 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantPerformance Restricted Stock Unit · Derivative | 450,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-135877 · ownership.xml · derivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2025-12-31 F1 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents a PRSU award granted on December 10, 2024 and vesting on December 31, 2025, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: (i) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven (as defined in the applicable PRSU grant notice) for the fiscal quarter ended June 30, 2025; (ii) 50% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended September 30, 2025 and (iii) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended December 31, 2025. F1 · price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: Represents a PRSU award granted on December 10, 2024 and vesting on December 31, 2025, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: (i) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven (as defined in the applicable PRSU grant notice) for the fiscal quarter ended June 30, 2025; (ii) 50% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended September 30, 2025 and (iii) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended December 31, 2025. F2 · derivative.expiration_date: Represents a PRSU award granted on December 10, 2024 and vesting on December 31, 2025, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: (i) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven (as defined in the applicable PRSU grant notice) for the fiscal quarter ended June 30, 2025; (ii) 50% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended September 30, 2025 and (iii) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended December 31, 2025. Read SEC document |
| October 24, 2024 Filed Nov 5, 2024 16:14 UTC | CUTERA INC CUTR · Entity 82936 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $0.65 | $0.00 |
DisclosureSEC source: 0001628280-24-045292 · wk-form4_1730841248.xml · derivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: COMMON STOCK · 20,000 shares Expires 2031-10-23 F1 · derivative.exercise_date: All shares vest on the earlier of 12 months from grant date, or on the day of the 2025 annual stockholder meeting, subject to the Reporting Person continuing to be a service provider of the Company. F2 · derivative.expiration_date: The expiration date is subject to earlier expiration upon the termination of the Reporting Person's service with the Company. Read SEC document |
| July 18, 2024 Filed Jul 22, 2024 21:23 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 24,162 | $1.90 | $45,907.80 |
DisclosureSEC source: 0000950170-24-085343 · ownership.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,324,354 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.88 to $1.99. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 17, 2024 Filed Jul 18, 2024 21:21 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 11,687 | $1.97 | $23,023.39 |
DisclosureSEC source: 0000950170-24-084662 · ownership.xml · nonDerivative · entry 2 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,348,516 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.95 to $2.02. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 16, 2024 Filed Jul 18, 2024 21:21 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 12,075 | $1.91 | $23,063.25 |
DisclosureSEC source: 0000950170-24-084662 · ownership.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,360,203 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.89 to $1.95. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 22:02 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 20,292 | $3.30 | $66,963.60 |
DisclosureSEC source: 0000950170-24-022231 · ownership.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,372,278 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.15 to $3.38. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 22:21 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 20,750 | $3.23 | $67,022.50 |
DisclosureSEC source: 0000950170-24-020321 · ownership.xml · nonDerivative · entry 2 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,392,570 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.10 to $3.34. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:21 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 20,851 | $3.23 | $67,348.73 |
DisclosureSEC source: 0000950170-24-020321 · ownership.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,413,320 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.10 to $3.32. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 22:02 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 23,958 | $2.96 | $70,915.68 |
DisclosureSEC source: 0000950170-24-018896 · ownership.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,434,171 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.84 to $3.04. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 23:19 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-002964 · doc4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,458,129 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 5, 2025, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 11, 2024 Filed Jan 12, 2024 23:00 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 9,516 | $3.16 | $30,070.56 |
DisclosureSEC source: 0001209191-24-001575 · doc4.xml · nonDerivative · entry 2 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,158,129 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.05 to $3.37. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 10, 2024 Filed Jan 12, 2024 23:00 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 10,013 | $3.01 | $30,139.13 |
DisclosureSEC source: 0001209191-24-001575 · doc4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,167,645 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.83 to $3.29. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 21, 2023 Filed Jul 25, 2023 23:50 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 6,551 | $2.04 | $13,364.04 |
DisclosureSEC source: 0001062993-23-015321 · form4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,177,658 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.01 to $2.08. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 20, 2023 Filed Jul 21, 2023 22:15 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 6,510 | $2.06 | $13,410.60 |
DisclosureSEC source: 0001062993-23-015169 · form4.xml · nonDerivative · entry 2 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,184,209 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.00 to $2.08. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 19, 2023 Filed Jul 21, 2023 22:15 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 6,479 | $2.07 | $13,411.53 |
DisclosureSEC source: 0001062993-23-015169 · form4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,190,719 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.03 to $2.14. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 19, 2023 Filed May 23, 2023 18:54 UTC | CUTERA INC CUTR · Entity 82936 | GrantCommon Stock | 11,894 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031748 · doc4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,894 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One third of the RSUs vest on May 19, 2024 and each anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 22:23 UTC | Venus Concept Inc. VERO · Entity 55304 | PurchaseEmployee Stock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $0.19 | $0.00 |
DisclosureSEC source: 0001362118-23-000025 · primary_doc.xml · derivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2033-03-24 F1 · derivative.exercise_date: The options vest with respect to 1/16th of the underlying Common Stock on each quarterly anniversary of the date of grant, subject to continued service through each applicable vesting date. Read SEC document |
| February 14, 2023 Filed Feb 15, 2023 21:43 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 13,647 | $5.58 | $76,150.26 |
DisclosureSEC source: 0001062993-23-003664 · form4.xml · nonDerivative · entry 2 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,197,198 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $5.41 to $5.72. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:43 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 25,154 | $5.49 | $138,095.46 |
DisclosureSEC source: 0001062993-23-003664 · form4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,210,845 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $5.38 to $5.56. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 21:02 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 285,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-002845 · form4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,235,999 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 9, 2024, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| October 20, 2022 Filed Oct 24, 2022 20:06 UTC | Neuronetics, Inc. STIM · Entity 6248 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $1.98 | $0.00 |
DisclosureSEC source: 0001062993-22-021053 · form4.xml · derivative · entry 2 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900,000 Underlying: Common Stock · 100,000 shares Expires 2030-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Twenty-five percent (25%) of the original grant of 1,000,000 options to purchase vested on July 14, 2021, and one forty-eighth (1/48th) of the remaining options shall vest each month thereafter, in each case subject to continuous service of the Reporting Person through such date. Read SEC document |
| October 20, 2022 Filed Oct 24, 2022 20:06 UTC | Neuronetics, Inc. STIM · Entity 6248 | Exercise / conversionCommon Stock | 100,000 | $1.98 | $198,000.00 |
DisclosureSEC source: 0001062993-22-021053 · form4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 950,999 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 18, 2022 Filed Jul 19, 2022 20:28 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 63,466 | $3.72 | $236,093.52 |
DisclosureSEC source: 0001062993-22-016494 · form4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 850,999 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.46 to $4.04. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 09, 2022 Filed Jun 14, 2022 00:10 UTC | Sientra, Inc. SIEN · Entity 108294 | GrantCommon Stock | 103,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-036510 · doc4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370,354 F1 · shares: The Restricted Stock Units shall vest on the earlier to occur of: (i) the day prior to the 2023 Annual Shareholders Meeting or (ii) on the one (1) year anniversary of the Annual Shareholders Meeting on which the Restricted Stock Award was granted, subject to continued service. Read SEC document |
| March 25, 2022 Filed Mar 28, 2022 17:08 UTC | Venus Concept Inc. VERO · Entity 55304 | GrantEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001362118-22-000025 · primary_doc.xml · derivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires 2032-03-25 F1 · derivative.exercise_date: The option vests with respect to 1/16th of the underlying Common Stock on each quarterly anniversary of the date of grant, subject to continued service through each applicable vesting date. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 23:05 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 283,912 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-003820 · form4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 914,465 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 9, 2023, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 21:17 UTC | Venus Concept Inc. VERO · Entity 55304 | PurchaseCommon Shares | 80,000 | $1.25 | $100,000.00 |
DisclosureSEC source: 0001567619-21-022255 · doc1.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the Keith J. Sullivan Revocable Trust Disclosed balance after: 80,000 Read SEC document |
| July 16, 2021 Filed Jul 19, 2021 21:32 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 93 | $13.64 | $1,268.52 |
DisclosureSEC source: 0001062993-21-006615 · form4.xml · nonDerivative · entry 2 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 630,553 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 21:32 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 50,893 | $13.46 | $684,912.90 |
DisclosureSEC source: 0001062993-21-006615 · form4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 630,646 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $13.29 to $13.61. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 10, 2021 Filed Jun 16, 2021 00:13 UTC | Sientra, Inc. SIEN · Entity 108294 | GrantCommon Stock | 16,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040771 · doc4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,048 F1 · shares: The Restricted Stock Units shall vest on the earlier to occur of: (i) the day prior to the 2022 Annual Shareholders Meeting or (ii) on the one (1) year anniversary of the Annual Shareholders Meeting on which the Restricted Stock Award was granted, subject to continued service. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Sientra, Inc. Class A Common Stock. Read SEC document |
| March 26, 2021 Filed Mar 31, 2021 00:56 UTC | Venus Concept Inc. VERO · Entity 55304 | GrantDirector Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.37 | $0.00 |
DisclosureSEC source: 0001567619-21-007252 · doc1.xml · derivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-03-26 F1 · derivative.exercise_date: The options vest with respect to 1/16th of the underlying Common Stock on each quarterly anniversary of the date of grant, subject to continued service through each applicable vesting date. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 23:10 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 45,632 | $17.96 | $819,550.72 |
DisclosureSEC source: 0000925421-21-000080 · edgar.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 681,539 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a performance restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $17.18 to $18.65. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 22:25 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantPerformance Restricted Stock Unit · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000925421-21-000078 · edgar.xml · derivative · entry 2 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F2 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The PRSU rights vest upon the Issuer's common stock achieving a volume weighted average price of $35 per share. F2 · derivative.exercise_date: Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The PRSU rights vest upon the Issuer's common stock achieving a volume weighted average price of $35 per share. F2 · derivative.expiration_date: Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The PRSU rights vest upon the Issuer's common stock achieving a volume weighted average price of $35 per share. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 22:25 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantPerformance Restricted Stock Unit · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000925421-21-000078 · edgar.xml · derivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. The PRSU rights vest upon the Issuer's comon stock achieving a volume weighted average price of $30 per share. F1 · derivative.exercise_date: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. The PRSU rights vest upon the Issuer's comon stock achieving a volume weighted average price of $30 per share. F1 · derivative.expiration_date: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. The PRSU rights vest upon the Issuer's comon stock achieving a volume weighted average price of $30 per share. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 21:25 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 125,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000925421-21-000063 · edgar.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 727,171 F1 · price: Common stock received for no consideration upon the satisfaction of performance criteria underlying an award of performance based restricted stock units. Read SEC document |
| January 26, 2021 Filed Jan 29, 2021 02:42 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 22,829 | $18.83 | $429,870.07 |
DisclosureSEC source: 0000925421-21-000058 · edgar.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 602,171 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $18.37 to $19.68. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 12, 2021 Filed Jan 14, 2021 21:12 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 125,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-21-000059 · edgar.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 625,000 F1 · price: Common stock received for no consideration upon the satisfaction of performance criteria underlying an award of performance based restricted stock units. Read SEC document |
| July 14, 2020 Filed Jul 16, 2020 21:19 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantEmployee Stock Option (right to buy) · Derivative | 1,000,000 | $0.00 Strike: $1.98 | $0.00 |
DisclosureSEC source: 0001192482-20-000626 · edgar.xml · derivative · entry 2 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2030-07-14 F3 · derivative.exercise_date: Twenty-five percent (25%) of the option to purchase shall vest on July 14, 2021, and one forty-eighth (1/48th) of the remaining shares subject to the option shall vest each month thereafter, in each case subject to continuous service of the Reporting Person through such date. Read SEC document |
| July 14, 2020 Filed Jul 16, 2020 21:19 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 500,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-20-000626 · edgar.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in four equal annual installments beginning on July 14, 2021, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.